Cobble, Michael E <br/><br/>
Saxagliptin for the treatment of type 2 diabetes mellitus: assessing cardiovascular data.  [electronic resource] 

 -  Cardiovascular diabetology  Jan 2012 
 - 6 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review 
<br/><br/><label>ISSN: </label>1475-2840 
<br/><br/><label>Standard No.: </label>10.1186/1475-2840-11-6  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adamantane--adverse effects<br/>Cardiovascular Diseases--etiology<br/>Clinical Trials as Topic<br/>Diabetes Complications--etiology<br/>Diabetes Mellitus, Type 2--complications<br/>Dipeptides--adverse effects<br/>Dipeptidyl-Peptidase IV Inhibitors--adverse effects<br/>Drug Therapy, Combination<br/>Evidence-Based Medicine<br/>Humans<br/>Patient Safety<br/>Proportional Hazards Models<br/>Risk Assessment<br/>Risk Factors<br/>Treatment Outcome